2014 Dodge Avenger SE
2.4 L • 4 • FWD • AT
1C3CDZAB0EN154213
Sales history: 1
• $1,250Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
2.4 L • 4 • FWD • AT
Odometer
96,380 mi ≈ 155,108 km
Primary damage
Front end
Docs
FL • Rebuild Salvage
Auction
VIN
1C3CDZAB0EN154213
Lot number
85710565
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Tallahassee, FL
Description
Fuel type
Gasoline
Body color
Black
Body type
Sedan
Generation
JS
Trim
SE
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Dodge models
2014 Dodge Avenger SE • 2.4 L • 4 cyl • FWD • Automatic • Copart Lot: 85710565 • VIN: 1C3CDZAB0EN154213
Find out more about this 2014 Dodge Avenger SE, available at the Copart salvage car auction as lot #85710565 in Tallahassee, FL. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 96,380 mi. This Black Dodge Avenger Sedan is equipped with Gasoline 2.4 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1C3CDZAB0EN154213 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
